Browsing Tag
Neuroscience 2024
1 post
Suven life sciences reports rapid-acting depression treatment breakthrough with ropanicant in phase-2a trial
Suven Life Sciences’ Ropanicant delivers rapid antidepressant effects in Phase-2a trial for MDD. See the results, safety profile, and what’s next.